As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...

US stock market today: Why Dow Jones Industrial Average falls while S&P 500 and Nasdaq Composite hold steady? US stock market today shows a...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

If you are putting fresh money into the stock market (or even looking to rejig your existing portfolio), it would be best not to react to w...

Global equity markets will continue hitting sudden air pockets and face turbulence. They are probably still not discounting the impact of a...

U.S. equity markets are set for a sharp rebound in IPOs in 2026, Goldman Sachs analysts said, forecasting proceeds quadrupling to a record ...

The Indian budget offers a modest economic boost with increased capital expenditure, focusing on strategic sectors. While positive for earn...

PHARMEXCIL leadership met with senior Indian government officials to strategize for global market expansion and policy alignment in the pha...

Biocon is set to fully integrate its biosimilar arm, Biocon Biologics. This move will make Biocon Biologics a wholly owned subsidiary. Bioc...

Biocon will strengthen its insulin business while advancing in GLP-1 therapies, with semaglutide in Phase-III trials and a planned 2027 Ind...

Chennai's office stock is set to surpass 100 million sq ft by 2026, driven by increased private equity investments. The city’s office marke...

BITS Pilani has won the Sathi project and received a grant of Rs 60 crore. It will establish advanced research facilities and a sophisticat...

In the Interim Budget, Finance Minister Nirmala Sitharaman introduced financial assistance for the procurement of biomass aggregation machi...

Promoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...

South Korea's top conglomerate said on Tuesday the investments through 2026 are expected to help Samsung drive long-term growth in strategi...

Biocon reported 20.26% increase in net profit for the quarter ended September 30 to Rs 89.22 crore on the back of strong sales.